Table 3.
Short- and long-term outcome of patients according to BMI and sarcopenia
| Sarcopenia (N = 54) | No sarcopenia (N = 66) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | MORB | MORT | OS | DFS | N | MORB | MORT | OS | DFS | |
| BMI ≤25 (N = 45) | 25 | 56 % | 12 % | 22 m | 22 m | 20 | 60 % | 0 % | 32 m | 29 m |
| BMI >25 (N = 75) | 29 | 55 % | 7 % | 25 m | 23 m | 46 | 54 % | 4 % | 28 m | 26 m |
| p value | NA | 0.82 | 0.52 | 0.36 | 0.35 | NA | 0.67 | 0.34 | 0.39 | 0.41 |
N number of patients in the specific subgroup, MORB overall morbidity, MORT in-hospital mortality, OS median overall survival in months, DFS median disease-free survival in months, NA not applicable